期刊文献+

脓毒症并发急性肾损伤患者外周血单个核细胞中微小RNA-16-5p、干扰素诱导跨膜蛋白3表达及临床意义 被引量:4

Expression and clinical significance of miR-16-5p and IFITM3 in peripheral blood mononuclear cells of patient with sepsis-associated acute kidney injury
下载PDF
导出
摘要 目的检测脓毒症及脓毒症并发急性肾损伤(sepsis-associated acute kidney injury,S-AKI)患者外周血单个核细胞中微小RNA-16-5p(microRNA-16-5p,miR-16-5p)、干扰素诱导跨膜蛋白3(interferon-induced transmembrane protein,IFITM3)表达情况,分析两者对S-AKI患者的临床意义。方法本研究以2019年2月至2021年2月武汉市蔡甸区人民医院确诊的脓毒症患者为研究对象,共纳入106例,将合并急性肾损伤(acute kidney injury,AKI)的脓毒症患者作为AKI组(52例),未合并AKI的患者为非AKI组(54例)。收集所有患者的血液样本3 mL并分离单核细胞,利用实时荧光定量技术检测外周血单个核细胞中miR-16-5p、IFITM3 mRNA的表达水平,酶联免疫吸附法测定外周血中白细胞介素1β(interleukin-1β,IL-1β)水平,全自动生化分析仪检测外周血中胱抑素(cysteine,Cys)和尿素氮(blood urea nitrogen,BUN)水平;比较两组间的临床指标及miR-16-5p、IFITM3 mRNA表达水平,Pearson法分析miR-16-5p、IFITM3 mRNA分别与BUN、Cys水平的相关性,以及miR-16-5p与IFITM3 mRNA表达水平的相关性,采用多元线性回归分析S-AKI患者miR-16-5p、IFITM3 mRNA表达水平的影响因素,受试者工作特性曲线(receiver operator characteristic curves,ROC)评估miR-16-5p和IFITM3 mRNA对脓毒症患者发生S-AKI的诊断价值。结果AKI组患者急性生理学与慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluationⅡ,APACHEⅡ)评分(15.67±4.39比13.31±3.56)、序贯器官衰竭评分(sequential organ failure assessment,SOFA)评分(5.62±1.28比4.89±1.41)、IL-1β[(22.03±5.78)mg/L比(10.44±3.05)mg/L]、Cys[(2.72±0.45)mg/L比(1.98±0.31)mg/L]和BUN[(7.93±2.24)μmol/L比(4.49±2.07)μmol/L]水平均高于非AKI组患者(P<0.05),AKI组患者的miR-16-5p(1.64±0.30比1.17±0.28)表达水平显著上调,IFITM3 mRNA(2.87±0.62比4.06±0.92)及蛋白(1.63±0.41比3.15±0.85)(r=0.560,P<0.05)水平呈正相关,IFITM3 mRNA表达水平与IL-1β(r=-0.754,P<0.05)、Cys(r=-0.554,P<0.05)、BUN(r=-0.695,P<0.05)水平呈负相关,miR-16-5p与IFITM3 mRNA的表达水平呈负相关(r=-0.496,P<0.05);多元线性回归分析结果显示,IL-1β升高、Cys升高是miR-16-5p、IFITM3 mRNA表达水平的影响因素(P<0.05);miR-16-5p、IFITM3 mRNA单一检测诊断脓毒症患者发生S-AKI的曲线下面积(area under the curve,AUC)分别为0.876(95%CI:0.809~0.944)、0.874(95%CI:0.811~0.938),miR-16-5p和IFITM3 mRNA联合检测的AUC为0.956(95%CI:0.929~0.992)。结论S-AKI患者中miR-16-5p表达上调,IFITM3表达下调,与S-AKI的病理过程密切相关,可能通过促进炎症反应加重肾损伤,有助于早期诊断S-AKI,为临床治疗S-AKI提供了有希望的靶点。 Objective To detect the expression of microRNA-16-5p(miR-16-5p)and interferon-induced transmembrane protein 3(IFITM3)in peripheral blood mononuclear cells of septic patients with sepsis-associated acute kidney injury(S-AKI)and examine the clinical significance of the two in S-AKI patients.Methods During February 2019 to February 2021,106 septic patients were selected as research subjects.Septic patients with acute kidney injury(AKI)were included in AKI group(n=52)and those without AKI in non-AKI group(n=54).The 3 ml of blood samples from all patients was harvested for separating monocytes,real-time fluorescent quantitative technology for detecting the expression levels of miR-16-5p and IFITM3 mRNA in peripheral blood mononuclear cells,enzyme-linked immunosorbent assay for determining the level of interleukin-1β(IL-1β)in peripheral blood,automatic biochemical analyzer for detecting the levels of cysteine(Cys)and blood urea nitrogen(BUN)in peripheral blood;clinical parameters and the expression levels of miR-16-5p and IFITM3 mRNA were compared between two groups,Pearson’s method was performed to analyze the correlation between miR-16-5p,IFITM3 mRNA and BUN/Cys level and the correlation between miR-16-5p and IFITM3 mRNA expression levels,multiple linear regression was utilized for examining the influencing factors of miR-16-5p and IFITM3 mRNA expression,receiver operator characteristic(ROC)curve was plotted for evaluating the diagnostic value of miR-16-5p and IFITM3 mRNA for S-AKI in septic patients.Results The acute physiology and chronic health evaluationⅡ(APACHEⅡ)score(15.67±4.39 vs 13.31±3.56),sequential organ failure assessment(SOFA)score(5.62±1.28 vs 4.89±1.41),levels of IL-1β[(22.03±5.78)mg/L vs(10.44±3.05)mg/L],Cys[(2.72±0.45)mg/L vs(1.98±0.31)mg/L]and BUN[(7.93±2.24)μmol/L vs(4.49±2.07)μmol/L]were higher in AKI group than those in non-AKI group(P<0.05),the expression level of miR-16-5p(1.64±0.30 vs 1.17±0.28)in AKI group was significantly up-regulated,the expression level of IFITM3 mRNA(2.87±0.62 vs 4.06±0.92)and protein(1.63±0.41 vs 3.15±0.85)were significantly down-regulated(P<0.05);the expression level of miR-16-5p in patient with S-AKI was positively correlated with the levels of IL-1β(r=0.531,P<0.05),Cys(r=0.482,P<0.05)and BUN(r=0.560,P<0.05),the expression level of IFITM3 mRNA was negatively correlated with the levels of IL-1β(r=-0.754,P<0.05),Cys(r=-0.554,P<0.05)and BUN(r=-0.695,P<0.05),the expression levels of miR-16-5p and IFITM3 mRNA were negatively correlated(r=-0.496,P<0.05);multiple linear regression analysis indicated that elevations of IL-1βand Cys were the influencing factors of miR-16-5p and IFITM3 mRNA expression levels(P<0.05);the area under the curve(AUC)s of miR-16-5p and IFITM3 mRNA single test for diagnosing S-AKI in septic patients were 0.876(95%CI:0.809~0.944)and 0.874(95%CI:0.811~0.938),the AUC of miR-16-5p and IFITM3 mRNA combined detection was 0.956(95%CI:0.929~0.992).Conclusion In S-AKI patients,the expression of miR-16-5p is up-regulated while the expression of IFITM3 down-regulated.Both are closely correlated with the pathological process of S-AKI.It may aggravate kidney injury by promoting inflammation,aid in an early diagnosis of S-AKI and provide a promising therapeutic target for S-AKI.
作者 陈旋 Chen Xuan(Wuhan Caidian District People's Hospital,Wuhan 430000,China)
出处 《临床肾脏病杂志》 2023年第1期45-51,共7页 Journal Of Clinical Nephrology
关键词 脓毒症 急性肾损伤 微小RNA-16-5p 干扰素诱导跨膜蛋白3 Sepsis Acute kidney injury MicroRNA-16-5p Interferon-induced transmembrane protein 3
  • 相关文献

参考文献4

二级参考文献11

  • 1Singer M, Deutschman CS, Seymour CW, et al. The Third In- ternational Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA,2016,315(8):801-810. DOI:I0.1001/ jama. 2016.0287.
  • 2Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock : for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA,2016,315(8):775-787. DOI: 10.1001/jama.2016.0289.
  • 3Seymour CW, Liu VX, lwashyna TJ, et al. Assessment of clln- ical criteria for sepsis: for the Third International Consensus Def- initions tbr Sepsis and Septic Shock (Sepsis-3) [ J]. JAMA, 2016,315(8) :762-774.D01: 10.1001/jama.2016.0288.
  • 4Bone RC, Balk RA, Cerra FB, et al. American Chest Physicians/Society of Critical Care Medicine Conference: definitions for sepsis and organ failure lines for the use of innovative therapies in sepsis [ J ] Med, 1992,20(6) : 864-874.
  • 5College of Consensus and guide- Crit Care Levy MM, Fink MP, Marshall JC, et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS In- ternational Sepsis Definitions Conference [ J]. Intensive Care Med, 2003,29 (4) : 530-538.
  • 6Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflam- matory response syndrome criteria in defining severe sepsis [ J ]. N Engl J Med, 2015,372(17) : 1629-1638. DOI: 10. 1056/NEJMoa- 1415236.
  • 7Vincent JL, Mira JP, Antonelli M. Sepsis: older and newer concepts. Lancet Respir Med, 2016, 4 ( 3 ) : 237-240. DOI: 10. 1016/$2213-2600( 15)00522-6.
  • 8Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock [ J ]. N Engl J Med,2015,372(14) : 1301-1311.DOI : 10.1056/NEJMoa1500896.
  • 9ARISE Investigators, ANZICS Clinieal Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock[ J]. N Engl J Med,2014,371 (16) : 1496-1506.DOI: 10. 1056/NEJMoa1404380.
  • 10ProCESS Investigators, Yealy DM, Kellum JA, et al. A ran- domized trial of protocol-based care for early septic shock [ J ] N Engl J Med,2014,370(18): 1683-1693. DOI: 10.1056/NEJ- Moa1401602.

共引文献229

同被引文献44

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部